{'fraction_non_alphanumeric': 0.015945330296127564, 'fraction_numerical': 0.018223234624145785, 'mean_word_length': 5.567164179104478, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Statins in the prevention of cardiovascular disease

Since their launch in the late 1980s, statins have become the most prescribed drugs worldwide. However, the 2014 NICE guidance extending their use to lower‐risk patients triggered controversy over their side‐effects and alleged overprescribing. This article gathers the views of clinicians and opinion leaders on the current place of statins in the prevention of cardiovascular disease.